首页> 外文OA文献 >The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

【2h】

The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

机译：在慢性期慢性髓性白血病患者中对伊马替尼甲磺酸盐治疗期间骨髓抑制作用的重要性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Thomas B. Sneed; Hagop M. Kantarjian; Moshe Talpaz; Susan OBrien; Mary Beth Rios; B. Nebiyou Bekele; Xian Zhou; Debra Resta; William Wierda; Stefan Faderl; Francis Giles; Jorge E. Cortes;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy. [J] . Rytting ME, Wierda WG Leukemia and lymphoma . 2004,第8期

机译：伊马替尼甲磺酸伊马替尼治疗两名慢性粒细胞白血病髓样增生期中枢神经系统复发。
2. Long-term safety and efficacy of imatinib mesylate (Gleevec?) in elderly patients with chronic phase chronic myelogenous leukemia: Results of the AFR04 study [J] . RousselotP., Cony-MakhoulP., NicoliniF., American Journal of Hematology . 2013,第1期

机译：甲磺酸伊马替尼（Gleevec？）在老年慢性期慢性粒细胞性白血病患者中的长期安全性和有效性：AFR04研究结果
3. Long-term safety and efficacy of imatinib mesylate (Gleevec?) in elderly patients with chronic phase chronic myelogenous leukemia: Results of the AFR04 study [J] . RousselotP., Cony-MakhoulP., NicoliniF., American Journal of Hematology . 2013,第1期

机译：伊马替尼的长期安全性和疗效（Gleevec？）在老年慢性期慢性髓性白血病患者中：AFR04研究的结果
4. Proteomic Analysis of the Cytoskeleton Regulation in Chronic Myelogenous Leukemia Cells JURL-MK1: Effect of Imatinib Mesylate Treatment [C] . Petr Halada, Katerina Peslova, Dana Grebenova, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：慢性髓性白血病细胞Jull-MK1中细胞骨架调控的蛋白质组学分析：伊马替尼甲磺酸盐处理的影响
5. Influences on physician recommendation for imatinib mesylate in chronic phase chronic myeloid leukemia patients. [D] . Iyer, Shrividya Sethuraman. 2003

机译：对慢性期慢性粒细胞白血病患者甲磺酸伊马替尼的医师推荐的影响。
6. Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy [O] . Qaiser Bashir, Marcos J. De Lima, John D. McMannis, -1

机译：在伊马替尼甲壳酸伊替尼酸甲酸盐治疗后完全细胞遗传学缓解慢性髓性白血病患者造血祖细胞收集
7. Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapy [O] . Hagop M. Kantarjian, Carlos E. Bueso-Ramos, Moshe Talpaz, 2005

机译：早期慢性期骨髓纤维化，慢性髓性白血病对伊马替尼甲磺酸盐治疗的意义

The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

著录项

引文网络

相似文献

相关主题

期刊订阅